Recent surveys by two leading investment banks spotlight trends in the spine market.Subscribe now to read the full analysis
Welcome to MyStrategist, an online experience like no other in the medical device industry.
With MyStrategist, quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and MedTech Strategist Market Pathways – now on an all-in-one, digital platform. We invite you to explore our coverage.
Think Strategically. Subscribe Today.
Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with MedTech Strategist Market Pathways.Subscribe Free Premier Issue Learn More
Device industry officials who are engaged in Brazil affairs praise the country’s regulatory agency, ANVISA, for employing a rigorous rule-making process to develop a policy for monitoring orthopedic implant prices to help counter corruption, while steering clear of pursuing direct price controls.Subscribe now to read the full analysis
Innovation Summit San Francisco, November 18-19th, is coming soon. Early-bird registration expires Sept. 30th!Register Learn More
In this week’s top news pick from MedTech Strategist Market Pathways: transcatheter mitral valve device developers jostle for advantage in their feedback to CMS as the agency reconsiders its coverage policies.Subscribe now to read the full analysis